TAHO Pharma begins patient dosing in US phase III trial of antithrombotic oral dissolving film, TAH3311: Taipei Wednesday, November 20, 2024, 16:00 Hrs [IST] TAHO Pharmaceuticals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback